This dysregulation exerts dual biological effects: ACSL4 enhances fatty acid accumulation by modulating lipid metabolism regulators (e.g., c-Myc and sterol regulatory element-binding proteins, SREBPs) to drive MM proliferation (Liang et al., 2023). This evidence concerns the gene ACSL4 and Miyoshi myopathy.